Rechercher dans ce blog

Jumat, 15 Juli 2022

Principal Technologies Corporate Update - Canada NewsWire

VANCOUVER, BC, July 15, 2022 /CNW/ - Principal Technologies Inc. (the "Company") (TSXV: PTEC.P), which is building a diverse portfolio of investments in healthcare technologies companies, is pleased to provide this corporate update to shareholders.

The Company is in the process of securing partnerships with international healthcare and med-tech associations in order to expand awareness and further strengthen the foothold of Principal Technologies in the healthcare community.

We are also expanding our advisory board by adding high profile individuals from the fields of healthcare, technology as well as business and finance, such as Geri Rainer - among others former CEO of one of the largest  Swiss Private Banks and trustee on several international multi billion dollar trusts. More information on him and other new advisory board members will be provided soon.

The Company is furthermore currently negotiating with several international target companies which we have identified with unique technologies and global growth potential that have an IP capable of enhancing medical treatment quality, cost efficiency and optimization of the patient pathway.

We are also pursuing additional financing opportunities.

In the meantime our portfolio companies, E&E CRO consulting as well as Vision Surgery AI, are performing above expectations.  These investments are further described in our news releases dated July, 8, 2021 and March 10, 2022.

We will provide more in depth information on all the above items in due course.

About Principal Technologies Inc. 

Principal Technologies Inc. (TSXV:PTEC.P), is building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential, that have achieved regional success. Principal Technologies will also focus on companies that have IP capable of enhancing medical treatment quality and efficiency, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. In addition to providing growth capital, the company also aims to support the growth of its portfolio with the expertise of its management team, board, and advisers.  
Learn more: https://principal-technologies.com/ 

ON BEHALF OF THE BOARD OF DIRECTORS:

For investor inquiries or further information, please contact:

Jerry Trent, Chief Executive Officer Principal Technologies Inc.: [email protected]

Cautionary Note Regarding Forward-Looking Information

This news release contains statements which constitute "forward-looking statements" and "forward-looking information" within the meaning of applicable securities laws (collectively, "forward-looking statements"),  including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking statements are often  identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe",  "estimate", "expect" or similar expressions and includes information regarding: (a) expectations regarding whether the Transaction will be consummated including whether the conditions to the consummation of the  Transaction; (b) the timing for completing the Transaction, if at all, and the conditions to such transaction;  and (c) expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking statements are not based on historical facts but instead reflect  the Company's management's expectations, estimates or projections concerning future results or events  based on the opinions, assumptions and estimates of management considered reasonable at the date the  statements are made. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance  should not be placed thereon, as unknown or unpredictable factors could have material adverse effects on  future results, performance or achievements of the resulting issuer. Among the key factors that could cause  actual results to differ materially from those projected in the forward-looking statements are the following:  the ability to consummate the Transaction; the ability to obtain requisite regulatory and shareholder  approvals and the satisfaction of other conditions to the consummation of the Transaction on the proposed  terms and schedule; the potential impact of the announcement or consummation of the Transaction on  relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes  in general economic, business and political conditions, including changes in the financial markets; changes  in applicable laws and regulations both locally and in foreign jurisdictions; compliance with extensive  government regulation; the risks and uncertainties associated with foreign markets; and the diversion of  management time on the Transaction. These forward-looking statements may be affected by risks and uncertainties in the business of E&E, the Company and general market conditions, including COVID-19.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. E&E and the Company do not intend, and do not assume any obligation, to update the forward-looking statements except as otherwise required by applicable law.

Completion of the Transaction is subject to a number of conditions, including but not limited to TSXV acceptance. There can be no assurance that the Transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the filing statement prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of the Company should be considered highly speculative.

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Principal Technologies Inc.

Adblock test (Why?)


Principal Technologies Corporate Update - Canada NewsWire
Read More

Tidak ada komentar:

Posting Komentar

Death of Boston Symphony principal who was also a NASA scientist - Slipped Disc

[unable to retrieve full-text content] Death of Boston Symphony principal who was also a NASA scientist    Slipped Disc Death of Boston Sy...